The deal marks the second billion-dollar acquisition by AbbVie in under a week. The company also acquired Immunogen and its ovarian cancer treatment for $10 billion.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
